Home
YU10
Company
Contract Research
Partnering & Pipeline
- Partnering, Collaboration & Pipeline
- Project design & Licensing
Platform & Technologies
News & Events
- News
- Events
Contact
- Contact
- Directions
Menu

Slider-Subpage-Yumab-news-events

News Archive

YUMAB announces new research & collaboration agreement with Merck - Read more

CORAT Therapeutics Takes Over the Fast Track Development of a Novel COVID-19 Antibody Drug Program - Read more

First hospitalized COVID-19 patient treated with COR-101 antibody - Read more

Human SARS-CoV-2 antibody COR-101 shows high efficacy in animal model - Read more

CORAT Therapeutics GmbH Mechanism of action for human SARS-CoV-2 antibody COR-101 identified - Read more

Innovation Award for CORAT’s COVID-19 antibody development - Read more

COVID-19: Media coverage of YUMAB’s activities - Read more

YUMAB COVID-19: First SARS-CoV-2 neutralizing antibody discovered - Read more

COVID-19: Lower Saxony’s health minister visits YUMAB - Read more

YUMAB partner Enleofen enters joint development with Boehringer Ingelheim - Read more

YUMAB GmbH

Science Campus Braunschweig-Süd
Inhoffenstr. 7
38124 Braunschweig – Germany

Phone: +49 531 481170-0
Fax: +49-531 481170-17

Newsletter

Want to know what we’re up to? Sign up for the newsletter here.

Newsletter Registration

More Information

Legal notice
Disclaimer, Data Privacy Statement
Terms and conditions
Sitemap